Evaluation of low dose famciclovir as herpes simplex virus and varicella zoster virus prophylaxis in cytomegalovirus low-risk solid organ transplant recipients.

Author: CrouchAshley, KottonCamille, LeMariesa, RogersChristin, ShaoSarah

Paper Details 
Original Abstract of the Article :
Famciclovir is a recommended option for herpes simplex virus (HSV) and varicella-zoster virus (VZV) prophylaxis in cytomegalovirus (CMV) low-risk solid organ transplant (SOT) recipients in current guidelines; however there is currently no data evaluating its use in SOT recipients. We conducted a mul...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/tid.13711

データ提供:米国国立医学図書館(NLM)

Famciclovir: A Desert Oasis for Transplant Recipients

Organ transplant recipients face a unique set of challenges, including the risk of developing viral infections. This study investigates the use of famciclovir, an antiviral medication, for preventing herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections in solid organ transplant recipients who are at low risk for cytomegalovirus (CMV). The researchers conducted a multicenter survey to assess current antiviral prophylaxis practices and evaluated the efficacy and safety of famciclovir in this population.

Finding the Right Oasis in the Desert of Post-Transplant Care

This study provides valuable insights into the use of famciclovir in post-transplant care. The researchers found that famciclovir was effective in preventing HSV and VZV infections in CMV low-risk transplant recipients, suggesting that it could be a valuable tool for protecting this vulnerable patient population. The study also highlighted the safety and tolerability of famciclovir, reassuring clinicians and patients about its potential use. This finding could be like discovering a hidden oasis in the vast desert of post-transplant care, offering a safe haven for patients seeking to prevent viral infections.

A Beacon of Hope in the Desert

This study is a reminder of the importance of ongoing research and innovation in the field of transplantation. The researchers' findings provide valuable information for clinicians and patients, guiding them in their efforts to manage the complex challenges of post-transplant care. It's a testament to the dedication of researchers who are constantly striving to find new ways to improve the lives of transplant recipients.

Dr.Camel's Conclusion

This study offers a glimmer of hope in the desert of post-transplant care, highlighting the potential of famciclovir in preventing viral infections. The findings provide valuable insights for clinicians and patients, guiding them in their efforts to manage the complex challenges of this unique patient population. Let's continue our journey through the desert of medical research, seeking to find new ways to improve the lives of those who rely on transplantation to live a fulfilling life.

Date :
  1. Date Completed 2021-11-02
  2. Date Revised 2021-11-02
Further Info :

Pubmed ID

34379876

DOI: Digital Object Identifier

10.1111/tid.13711

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.